GW Pharma
Latest round
- Series A
Last raised
- Sep 2021
Total raised
- Undisclosed
Investors
- 5
About GW Pharma
Based in Beijing, China and established in 2016, GW Pharma is a pharmaceutical company that focuses on the research and development of drugs in the spiritual field. The company's main product is drug GW117. GW117 is applied to depression, anxiety and other diseases. It also has a CNS efficacy evaluation model and a rapid screening platform for new chemical entities.
Who invested in GW Pharma
5 investors across 3 rounds
See all investors in GW Pharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about GW Pharma
Who invested in GW Pharma?
GW Pharma has 5 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has GW Pharma raised?
GW Pharma has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did GW Pharma last raise money?
GW Pharma's most recent round on record is a Series A, in Sep 2021.
What does GW Pharma do?
Based in Beijing, China and established in 2016, GW Pharma is a pharmaceutical company that focuses on the research and development of drugs in the spiritual field.
Where is GW Pharma headquartered?
GW Pharma is headquartered in Beijing, China.
Which VCs invest in companies like GW Pharma?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at GW Pharma's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like GW Pharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.